Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acetaminophen misconceptions.

Barry H Rumack1

  • 1University of Colorado School of Medicine, Greenwood Village, CO 80121, USA. barry@rumack.com

Hepatology (Baltimore, Md.)
|July 9, 2004
PubMed
Summary

Understanding acetaminophen pharmacokinetics clarifies clinical use. Therapeutic doses are safe with ethanol or fasting, but overdose risk increases in chronic alcohol abusers due to CYP2E1 and glutathione interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Out-of-hospital assessment and triage of paracetamol (acetaminophen) exposure in the United States and Canada: a consensus guideline.

Clinical toxicology (Philadelphia, Pa.)·2025
Same author

Clinically relevant therapeutic approaches against acetaminophen hepatotoxicity and acute liver failure.

Biochemical pharmacology·2024
Same author

Fifty years of paracetamol (acetaminophen) poisoning: the development of risk assessment and treatment 1973-2023 with particular focus on contributions published from Edinburgh and Denver.

Clinical toxicology (Philadelphia, Pa.)·2024
Same author

Lack of mitochondrial Cyp2E1 drives acetaminophen-induced ER stress-mediated apoptosis in mouse and human kidneys: Inhibition by 4-methylpyrazole but not N-acetylcysteine.

Toxicology·2023
Same author

Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement.

JAMA network open·2023
Same author

Failure of Risk Assessment After Paracetamol Overdose-A Short Communication.

Therapeutic drug monitoring·2022

Area of Science:

  • Pharmacology
  • Toxicology
  • Clinical Medicine

Background:

  • Acetaminophen (APAP) pharmacokinetics are crucial for safe clinical use.
  • Misconceptions regarding APAP metabolism and risk factors persist.
  • Factors like ethanol consumption and nutritional status require careful consideration.

Purpose of the Study:

  • To clarify the pharmacokinetics of acetaminophen.
  • To evaluate the impact of ethanol and nutrition on acetaminophen safety.
  • To investigate the role of specific enzymes and metabolites in acetaminophen toxicity.

Main Methods:

  • Review of pharmacokinetic data related to acetaminophen.
  • Analysis of enzyme patterns (e.g., CYP2E1) and metabolite levels (e.g., glutathione).
  • Correlation of acetaminophen levels with time, ethanol intake, and nutritional status.

Main Results:

  • Therapeutic acetaminophen doses show no increased risk with ethanol or fasting.
  • Acetaminophen overdose in chronic alcohol abusers can lead to more severe hepatotoxicity.
  • Simultaneous evaluation of CYP2E1 and glutathione is essential for understanding toxicity.
  • Glucuronidation capacity is generally not a limiting factor except in massive overdoses.

Conclusions:

  • Accurate understanding of acetaminophen pharmacokinetics reduces clinical misconceptions.
  • Ethanol and fasting do not pose significant risks at therapeutic acetaminophen doses.
  • Chronic alcohol use exacerbates acetaminophen-induced hepatotoxicity via specific metabolic pathways.
  • Targeted evaluation of CYP2E1 and glutathione is critical for managing acetaminophen overdose risk.

Related Experiment Videos